The Severe Acute Respiratory Syndrome

[1]  P. Woo,et al.  Identification of a Novel Coronavirus in Bats , 2005, Journal of Virology.

[2]  K. Kain,et al.  Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus , 2005, The Journal of infectious diseases.

[3]  Y. Guan,et al.  The aetiology, origins, and diagnosis of severe acute respiratory syndrome , 2004, The Lancet Infectious Diseases.

[4]  Lirong Chen,et al.  Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells , 2004, Journal of Virology.

[5]  R. Crystal,et al.  Macaque Model for Severe Acute Respiratory Syndrome , 2004, Journal of Virology.

[6]  L. Anderson,et al.  Laboratory Diagnosis of Four Recent Sporadic Cases of Community-acquired SARS, Guangdong Province, China , 2004, Emerging infectious diseases.

[7]  H. Deng,et al.  Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus Infection , 2004, The Journal of Infectious Diseases.

[8]  P. Woo,et al.  Viral Loads in Clinical Specimens and SARS Manifestations , 2004, Emerging infectious diseases.

[9]  Herman Tse,et al.  Identification of Novel Small-Molecule Inhibitors of Severe Acute Respiratory Syndrome-Associated Coronavirus by Chemical Genetics , 2004, Chemistry & Biology.

[10]  Christl A. Donnelly,et al.  SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts , 2004, Emerging infectious diseases.

[11]  S. Morikawa,et al.  A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice , 2004, International immunology.

[12]  A. Ahuja,et al.  Imaging in Severe Acute Respiratory Syndrome , 2004 .

[13]  A. Gorbalenya,et al.  Severe Acute Respiratory Syndrome Coronavirus Phylogeny: toward Consensus , 2004, Journal of Virology.

[14]  J. Sung,et al.  Association of Human-Leukocyte-Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome , 2004, The Journal of infectious diseases.

[15]  Jing Li,et al.  Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome , 2004, Infection and Immunity.

[16]  H. Doerr,et al.  Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus , 2004, Cellular and Molecular Life Sciences CMLS.

[17]  N. Zhong.  Management and prevention of SARS in China. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[18]  O. O’neill.  Informed consent and public health. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[19]  M. Iturriza-Gómara,et al.  Laboratory diagnosis of SARS. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[20]  C. Fraser,et al.  Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  L. Ren,et al.  Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells , 2004, Journal of Virology.

[22]  J. Sung,et al.  Persistent infection of SARS coronavirus in colonic cells in vitro , 2004, Journal of medical virology.

[23]  B. Murphy,et al.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.

[24]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[25]  Shuangli Li,et al.  Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. , 2004, DNA and cell biology.

[26]  Hsuan-Cheng Huang,et al.  Small molecules targeting severe acute respiratory syndrome human coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Poon,et al.  Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein , 2004, Virology.

[28]  H. Humphreys,et al.  Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  Xiaolei Yin,et al.  Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies , 2004, Journal of Virology.

[30]  H. Hsieh,et al.  Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide , 2004, Antimicrobial Agents and Chemotherapy.

[31]  S. Teoh,et al.  The severe acute respiratory syndrome coronavirus in tears , 2004, British Journal of Ophthalmology.

[32]  B. Murphy,et al.  Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Kuiken,et al.  Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets , 2004, The Lancet.

[34]  B. Murphy,et al.  Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS , 2004, The Lancet.

[35]  A. Lo,et al.  Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2) , 2004, The Journal of pathology.

[36]  J. Sung,et al.  Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients , 2004, Clinical Microbiology and Infection.

[37]  Kuender D Yang,et al.  Altered p38 Mitogen-Activated Protein Kinase Expression in Different Leukocytes with Increment of Immunosuppressive Mediators in Patients with Severe Acute Respiratory Syndrome1 , 2004, The Journal of Immunology.

[38]  G. Fey,et al.  Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor , 2004, Biochemical and Biophysical Research Communications.

[39]  R. Weinstein.  Planning for epidemics--the lessons of SARS. , 2004, The New England journal of medicine.

[40]  K. Subbarao,et al.  pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN , 2004, Journal of Virology.

[41]  H. Field,et al.  Epidemiologic Clues to SARS Origin in China , 2004, Emerging infectious diseases.

[42]  S. Poutanen,et al.  Transmission and control of SARS , 2004, Current infectious disease reports.

[43]  Weifeng Chen,et al.  T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Specific T-Cell Immune Response in Patients Who Recover from SARS , 2004, Journal of Virology.

[44]  Eric J. Snijder,et al.  Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase , 2004, Journal of Virology.

[45]  J. Lepault,et al.  Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Peiris,et al.  Severe acute respiratory syndrome among children. , 2004, Pediatrics.

[47]  Huang Xiaojun,et al.  The life cycle of SARS coronavirus in Vero E6 cells† , 2004, Journal of medical virology.

[48]  W. Lim,et al.  Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome , 2004, The Lancet.

[49]  M. Enserink.  One Year After Outbreak, SARS Virus Yields Some Secrets , 2004, Science.

[50]  Y. Guan,et al.  In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds , 2004, Journal of Clinical Virology.

[51]  Qingling Zhang,et al.  Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.

[52]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[53]  Jindrich Cinatl,et al.  HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus , 2004, Biochemical and Biophysical Research Communications.

[54]  T. Rainer.  Severe acute respiratory syndrome: clinical features, diagnosis, and management , 2004, Current opinion in pulmonary medicine.

[55]  Tae Woo Kim,et al.  Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.

[56]  S. Günther,et al.  Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus , 2004, Journal of Clinical Microbiology.

[57]  W. Thomas,et al.  Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor , 2004, Journal of Virology.

[58]  B. Moss,et al.  Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Y. Yap,et al.  Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs , 2004, Bioorganic & Medicinal Chemistry.

[60]  F. Aoki,et al.  Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α , 2004, The Journal of infectious diseases.

[61]  P. Openshaw.  What does the peripheral blood tell you in SARS? , 2004, Clinical and experimental immunology.

[62]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[63]  Gary J. Nabel,et al.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice , 2004, Nature.

[64]  J. Kwang,et al.  Immunological Characterization of the Spike Protein of the Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Clinical Microbiology.

[65]  Tzei-Yi Lin,et al.  Detection of Severe Acute Respiratory Syndrome–Associated Coronavirus in Pneumocytes of the Lung , 2004, American journal of clinical pathology.

[66]  B. Lim,et al.  Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs , 2004, Emerging infectious diseases.

[67]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[68]  M. Klempner,et al.  Crossing the species barrier--one small step to man, one giant leap to mankind. , 2004, The New England journal of medicine.

[69]  A. Debnath,et al.  Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors , 2004, The Lancet.

[70]  D. Fidler.  Germs, governance, and global public health in the wake of SARS. , 2004, The Journal of clinical investigation.

[71]  Guoping Zhao,et al.  Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China , 2004, Science.

[72]  G. Simmons,et al.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Peiris,et al.  Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids , 2004, Clinical and experimental immunology.

[74]  Y. Guan,et al.  Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings , 2004, Thorax.

[75]  S. Tsai,et al.  Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Wenhui Li,et al.  Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Ton de Jong,et al.  Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques , 2004, Nature Medicine.

[78]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[79]  C. Hon,et al.  Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments , 2004, Biochemical and Biophysical Research Communications.

[80]  K. Tao,et al.  Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine , 2004, Immunology Letters.

[81]  A. Pichlmair,et al.  The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein , 2004, Journal of Clinical Virology.

[82]  L. Babiuk,et al.  Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference , 2004, FEBS Letters.

[83]  J. Xie,et al.  Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome , 2004, The Journal of infectious diseases.

[84]  W. Travis,et al.  Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. , 2004, Archives of pathology & laboratory medicine.

[85]  Stefan Ma,et al.  Secondary Household Transmission of SARS, Singapore , 2004, Emerging infectious diseases.

[86]  Y. Guan,et al.  Detection of SARS Coronavirus in Patients with Suspected SARS , 2004, Emerging infectious diseases.

[87]  A. Schuchat,et al.  Superspreading SARS Events, Beijing, 2003 , 2004, Emerging infectious diseases.

[88]  Peter B. Jahrling,et al.  Interferon-β 1a and SARS Coronavirus Replication , 2004, Emerging infectious diseases.

[89]  Joseph S. Bresee,et al.  Cluster of SARS among Medical Students Exposed to Single Patient, Hong Kong , 2004, Emerging infectious diseases.

[90]  Xiaolei Yin,et al.  Expression cloning of functional receptor used by SARS coronavirus , 2004, Biochemical and Biophysical Research Communications.

[91]  G. Tse,et al.  Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases , 2004, The Journal of pathology.

[92]  Y. Guan,et al.  Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome , 2004, The Lancet.

[93]  K. Kain,et al.  Severe Acute Respiratory Syndrome–associated Coronavirus in Lung Tissue , 2004, Emerging infectious diseases.

[94]  J. Bartlett.  Virology: SARS virus infection of cats and ferrets , 2004 .

[95]  Xiaolei Yin,et al.  Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. , 2004, The Journal of infectious diseases.

[96]  R. Brilli,et al.  Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. , 2004, Pediatrics.

[97]  Chi-kong Li,et al.  Inflammatory cytokine profile in children with severe acute respiratory syndrome. , 2004, Pediatrics.

[98]  J. Dennis,et al.  Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. , 2003, JAMA.

[99]  M. Chan-yeung,et al.  High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. , 2003, American journal of respiratory and critical care medicine.

[100]  W. Bellini,et al.  Effects of a SARS-associated coronavirus vaccine in monkeys , 2003, The Lancet.

[101]  M. Bernstein,et al.  Ethics and SARS: lessons from Toronto , 2003, BMJ : British Medical Journal.

[102]  D. Cavanagh.  Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus , 2003, Avian pathology : journal of the W.V.P.A.

[103]  S. Siddell,et al.  Potential for antiviral treatment of severe acute respiratory syndrome , 2003, Current opinion in infectious diseases.

[104]  R. Rappuoli,et al.  SARS — beginning to understand a new virus , 2003, Nature Reviews Microbiology.

[105]  L. Poon,et al.  Serial Analysis of the Plasma Concentration of SARS Coronavirus RNA in Pediatric Patients with Severe Acute Respiratory Syndrome , 2003, Clinical chemistry.

[106]  J. Sung,et al.  Quantitative Analysis and Prognostic Implication of SARS Coronavirus RNA in the Plasma and Serum of Patients with Severe Acute Respiratory Syndrome , 2003 .

[107]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[108]  C. Chu,et al.  SARS: prognosis, outcome and sequelae , 2003, Respirology.

[109]  O. Tsang,et al.  Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection , 2003, Emerging infectious diseases.

[110]  J. Sung,et al.  Severe Acute Respiratory Syndrome–associated Coronavirus Infection , 2003, Emerging infectious diseases.

[111]  Albert D. M. E. Osterhaus,et al.  SARS virus infection of cats and ferrets , 2003, Nature.

[112]  J. Peiris,et al.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 , 2003, The Lancet.

[113]  Ralph S. Baric,et al.  Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[114]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[115]  Hisashi Moriguchi,et al.  Treatment of SARS with human interferons , 2003, The Lancet.

[116]  J. Sung,et al.  Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection , 2003 .

[117]  J. Sung,et al.  Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection , 2003, Gastroenterology.

[118]  P. Tambyah,et al.  Severe Acute Respiratory Syndrome: Lessons from Singapore , 2003, Emerging infectious diseases.

[119]  Stephen E. Lapinsky,et al.  Illness in Intensive Care Staff after Brief Exposure to Severe Acute Respiratory Syndrome , 2003, Emerging infectious diseases.

[120]  Y. Guan,et al.  Early diagnosis of SARS Coronavirus infection by real time RT-PCR , 2003, Journal of Clinical Virology.

[121]  J. Loo,et al.  Association of HLA class I with severe acute respiratory syndrome coronavirus infection , 2003, BMC Medical Genetics.

[122]  Narinder Paul,et al.  Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. , 2003, Radiology.

[123]  J. Sung,et al.  Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. , 2003, Radiology.

[124]  H. Bekedam,et al.  Role of China in the Quest to Define and Control Severe Acute Respiratory Syndrome , 2003, Emerging infectious diseases.

[125]  S. Lai,et al.  Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates , 2003, Emerging infectious diseases.

[126]  J. Sung,et al.  Human Metapneumovirus Detection in Patients with Severe Acute Respiratory Syndrome , 2003, Emerging infectious diseases.

[127]  Lanjuan Li,et al.  SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients , 2003, Journal of Clinical Virology.

[128]  E. Galanis,et al.  Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[129]  S. Ng.  Possible role of an animal vector in the SARS outbreak at Amoy Gardens , 2003, The Lancet.

[130]  Y. Guan,et al.  Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage , 2003, Journal of Molecular Biology.

[131]  P. Hawkey,et al.  Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. , 2003, Journal of Medical Microbiology.

[132]  J. Sung,et al.  Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. , 2003, Radiology.

[133]  Wenyuan Gao,et al.  Is traditional Chinese medicine useful in the treatment of SARS? , 2003, Phytotherapy research : PTR.

[134]  Junya Fukuoka,et al.  Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore , 2003, Human Pathology.

[135]  Anil T Ahuja,et al.  Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. , 2003, Radiology.

[136]  S. Günther,et al.  Severe acute respiratory syndrome: identification of the etiological agent , 2003, Trends in Molecular Medicine.

[137]  Y. Chan,et al.  Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) , 2003, Thorax.

[138]  H. Doerr,et al.  Treatment of SARS with human interferons , 2003, The Lancet.

[139]  J. Peiris,et al.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome , 2003, The Lancet.

[140]  Arul Earnest,et al.  Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.

[141]  Deepali Kumar,et al.  Severe Acute Respiratory Syndrome (SARS) in a Liver Transplant Recipient and Guidelines for Donor SARS Screening , 2003, American Journal of Transplantation.

[142]  S. Tsui,et al.  Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[143]  D. Luk,et al.  Severe acute respiratory syndrome in children: Experience in a regional hospital in Hong Kong* , 2003, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[144]  G. Zeng,et al.  Our strategies for fighting severe acute respiratory syndrome (SARS). , 2003, American journal of respiratory and critical care medicine.

[145]  N. Müller,et al.  Severe acute respiratory syndrome: radiographic and CT findings. , 2003, AJR. American journal of roentgenology.

[146]  Xinchun Chen,et al.  Chest X-ray imaging of patients with SARS. , 2003, Chinese medical journal.

[147]  K. Wong,et al.  Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report. , 2003, The Journal of bone and joint surgery. American volume.

[148]  J. Sung,et al.  Imaging of severe acute respiratory syndrome in Hong Kong. , 2003, AJR. American journal of roentgenology.

[149]  M. Avendaño,et al.  Clinical course and management of SARS in health care workers in Toronto: a case series. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[150]  C. Fraser,et al.  Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.

[151]  C. Dye,et al.  Modeling the SARS Epidemic , 2003, Science.

[152]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[153]  A. Yassi,et al.  Severe acute respiratory syndrome :Guidelines were drawn up collaboratively to protect healthcare workers in British Columbia , 2003, BMJ : British Medical Journal.

[154]  J. Sung,et al.  Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis , 2003, BMJ : British Medical Journal.

[155]  J. Sung,et al.  Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study , 2003, BMJ : British Medical Journal.

[156]  H. Doerr,et al.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.

[157]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[158]  Elizabeth Rea,et al.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.

[159]  Zhaohui Lu,et al.  [Lung pathology of severe acute respiratory syndrome]. , 2003, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[160]  N. Nagata,et al.  Laboratory and Epidemiology Communications SARS Coronavirus-Infected Cells in Lung Detected by New In Situ Hybridization Technique , 2003 .

[161]  J. Zhan,et al.  A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China. , 2003, Chinese medical journal.

[162]  Jianghong Chen,et al.  Early X-ray and CT appearances of severe acute respiratory syndrome: an analysis of 28 cases. , 2003, Chinese medical journal.

[163]  V. Wong,et al.  Treatment of severe acute respiratory syndrome with convalescent plasma. , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.

[164]  K. Holmes.  SARS coronavirus: a new challenge for prevention and therapy. , 2003, The Journal of clinical investigation.

[165]  Y. Leo,et al.  Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts , 2003, Emerging infectious diseases.

[166]  Y. Guan,et al.  Rapid Diagnosis of a Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS) , 2003, Clinical chemistry.

[167]  L. Enjuanes,et al.  The SARS Coronavirus: A Postgenomic Era , 2003, Science.

[168]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[169]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[170]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[171]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[172]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[173]  Philip M. Long,et al.  Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection , 2003, The Lancet.

[174]  N. Müller,et al.  Radiologic Manifestations of Severe Acute Respiratory Syndrome , 2003 .

[175]  K. Stöhr.  A multicentre collaboration to investigate the cause of severe acute respiratory syndrome , 2003, The Lancet.

[176]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[177]  Malik Peiris,et al.  Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.

[178]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[179]  Arthur S Slutsky,et al.  Identification of severe acute respiratory syndrome in Canada. , 2003, The New England journal of medicine.

[180]  P. Chan,et al.  Clinical presentations and outcome of severe acute respiratory syndrome in children , 2003, The Lancet.

[181]  M. Chan-yeung,et al.  A cluster of cases of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[182]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[183]  K. Yuen,et al.  Development of a standard treatment protocol for severe acute respiratory syndrome , 2003, The Lancet.

[184]  N. Müller,et al.  SARS: imaging of severe acute respiratory syndrome. , 2003, AJR. American journal of roentgenology.

[185]  H. Field,et al.  Managing emerging diseases borne by fruit bats (flying foxes), with particular reference to henipaviruses and Australian bat lyssavirus , 2003, Journal of applied microbiology.

[186]  J. Peiris,et al.  Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) , 2003, The Lancet.

[187]  Wei-min Zhou,et al.  [Chlamydia-like and coronavirus-like agents found in dead cases of atypical pneumonia by electron microscopy]. , 2003, Zhonghua yi xue za zhi.

[188]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[189]  Joshua Lederberg,et al.  Microbial Threats to Health: Emergence, Detection, and Response , 2003 .

[190]  Architectural Studies of Air Flow at Amoy Gardens , Kowloon Bay , Hong Kong , and its Possible Relevance to the Spread of SARS status report , 2003 .

[191]  Y. Guan,et al.  Inhibition of SARS-associated coronavirus infection and replication by RNA interference. , 2003, JAMA.

[192]  S. Ansart,et al.  [Severe acute respiratory syndrome: update]. , 2003, La Revue de medecine interne.

[193]  S. Twu,et al.  Update: outbreak of severe acute respiratory syndrome--worldwide, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[194]  L. Enjuanes,et al.  Virology. The SARS coronavirus: a postgenomic era. , 2003, Science.

[195]  Global surveillance for severe acute respiratory syndrome (SARS). , 2003, Releve epidemiologique hebdomadaire.

[196]  Outbreak of severe acute respiratory syndrome--worldwide, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[197]  J. Gerberding,et al.  Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[198]  F. Hayden,et al.  Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[199]  C. Olsen.  A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination , 1993, Veterinary Microbiology.

[200]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[201]  K. Johnson.  An Update. , 1984, Journal of food protection.

[202]  K. Shortridge,et al.  AN INFLUENZA EPICENTRE? , 1982, The Lancet.

[203]  C. Dolea,et al.  World Health Organization , 1949, International Organization.